opening price, page-14

Hi Retra,

A take over could be on the cards.

This company has around $100 Million Cash in the bank and will be able to sit back and the Royalties will keep coming in.
Royalities for the next few years from Relenza alone could be running in the hundreds of Millions.

Remember the Mcap right now is still only around $280 Million from which about $100 Million in cash.

So even a non expert can see that Relenza alone is capable of delivering Royalies many times the current true Marketcap of the the whole company.

And as I said before we still have Lani and the other products in the clinic.

The company is still very cheap imho.

And remember we can expect soon the new broker reports who would be upping the valuation for Biota.

They are always good running behind and this time will be no different.

It will spark more buying from those investors who need to see a broker report before they feel they can buy a share.

So I think you are right Biota is an undervalued Cash Cow which is loaded with Cash and only have to sit back to wait for the royalties to come in.

What more would a predator want???


good luck

jojo